The supplied BMJ Open source text did not contain the SinocaRT trial protocol. Instead, the document was a website access-block notice generated by a security service (Cloudflare). The block message prevented retrieval of any clinical or methodological content. The only concrete information present in the source was that access was blocked and a Cloudflare Ray ID string; no protocol content, trial methods, or results were included in the provided source text.
Because this source is the sole document provided for rewriting, this article limits itself to summarising what is verifiably present in that blocked page and to listing which trial details are absent. No clinical facts, numbers, or recommendations about the SinocaRT trial can be inferred or invented beyond what is explicitly indicated by the original article title.
The original article title references a randomised phase II protocol called SinocaRT addressing dose-painting after multi-block endoscopic endonasal surgery in sinonasal tumours. From the title alone we can note the trial appears to concern postoperative radiotherapy strategies following endoscopic endonasal resection of sinonasal tumours, and that dose-painting is a planned radiotherapy approach under investigation. However, the source text did not contain any supporting detail about trial rationale, objectives, radiation technique, or the surgical approach beyond these title terms.
The blocked source therefore does not provide definitions, inclusion or exclusion criteria, treatment arms, comparator details, or outcome measures for the SinocaRT study. Any description beyond acknowledging those terms would be speculative and is intentionally omitted.
The following protocol components would normally be expected in a published phase II trial protocol but were not present in the provided source due to the access block:
Trial hypothesis, primary and secondary objectives, and rationale for dose-painting.
Detailed description of the multi-block endoscopic endonasal surgery technique and perioperative care.
Radiation planning and delivery parameters, including target volumes, dose levels, and dose-painting methodology.
Eligibility criteria (inclusion and exclusion), recruitment strategy, and participating sites.
Randomisation scheme, allocation concealment, and blinding (if applicable).
Sample size calculation, statistical analysis plan, and primary endpoint definition.
Safety monitoring, adverse event reporting, and any data monitoring committee arrangements.
Ethical approvals, informed consent procedures, and trial registration details.
None of the above elements were available in the blocked-source text, and therefore cannot be summarised from this source.
The blocked page suggests a site-access issue rather than that the article does not exist. To obtain the protocol, the following steps are reasonable to pursue (these are process suggestions; the blocked source itself did not provide pathway details beyond the block message):
Access BMJ Open using an alternative network or device if a network-specific block is in effect.
Contact the BMJ Open helpdesk or site administrator to report the block and request access, referencing the article title and any available citation details.
Search for the SinocaRT protocol by title in bibliographic databases or the journal’s table of contents for the relevant issue; the blocked source did not provide DOI, authors, or issue details.
If institutional access is available, use institutional library services to retrieve the full-text article or request it via interlibrary loan.
Contact corresponding authors listed on the journal site (not present in the blocked text) or the trial sponsor to request the protocol or related materials.
The provided source did not include contact details, DOI, or other persistent identifiers; those items must be obtained from the journal platform once access is available.
From the supplied source we can only confirm that the SinocaRT protocol exists as an article title and that the BMJ Open page was inaccessible at the time of retrieval. No clinical guidance, trial procedures, or outcomes can be extracted from the blocked page. Clinicians and researchers should not rely on this blocked-source text for clinical decisions or for trial design insight. Retrieval of the full protocol and any supplementary materials from the journal or trial authors is required before clinical interpretation, citation, or incorporation into practice or research planning.
If you can provide an accessible copy of the BMJ Open article or another source that contains the SinocaRT protocol content, I can produce a full editorial rewrite and detailed clinical summary based strictly on that source material.